Stock fact sheet · data as of
iRhythm Technologies, Inc. (IRTC): fair value, margin of safety and Wheel Score
Healthcare · Medical - Devices · United States · Speculative / Distressed
Is IRTC undervalued?
IRTC closed at 109.35 on 16 Oct 2026, more than 30% above the GLS average fair value of 55.77. Only 0 of the 2 models that produced a value sit above the price. By our models the shares are priced well beyond what the filed earnings, cash flow and book value support; the Sunday Scan drops names like this at the "below fair value" rule.
Only 2 of the nine models produced a value (DCF, 10 Cap); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.
The nightly engine files IRTC under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.
Nine valuation models for IRTC
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 78.69 | -28% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | - | - | The most a defensive investor pays for the earnings and book value per share; no value tonight |
| Graham Growth | - | - | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight |
| Lynch | - | - | EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight |
| GLS Growth | - | - | EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight |
| 10 Cap | 32.85 | -70% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | - | - | Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | - | - | Earnings power value: current EPS capitalised at 9% with no growth; no value tonight |
| Zombie (liquidation) | -4.99 | -105% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 174.88 | +60% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is weak: IRTC passes 4 of the nine Piotroski tests. Our screens drop the stock at the health rule; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 2.3 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.
Returns on capital are thin or negative - ROIC -5.0%, ROE -29.2%, ROA -4.4% - with debt at 4.79 times equity and a free-cash-flow yield of 1.1%. Debt of 4.79 times equity is on the high side for the sector and is worth checking against the cash flow before treating the stock as a long-term hold.
iRhythm Technologies, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Commercial Payors 69%, Healthcare Institutions 23%, Non Contracted Third Party Payors 9% (quarter Q2 FY2026).
Institutional ownership scores 10/10, insider activity 1/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 4 / 9 | ROIC | -5.0% |
|---|---|---|---|
| GLS Moat | 2.3 / 10 | ROE | -29.2% |
| Debt / equity | 4.79 | ROA | -4.4% |
| Free-cash-flow yield | 1.1% | Payout ratio | 0% |
| Institutions | 10 / 10 | Insiders · Congress | 1 · 5 / 10 |
Wheel Score 45: Weak
IRTC scores 45 out of 100 on the Wheel Score, in the Weak band (under 50), capped at 45 because the engine files it as Speculative / Distressed. Value 0/25, Health 9/20, Moat 3/15, Premium 20/20, Stability 13/20. The score is not a judgement on the company; it says the price, quality and premium do not line up for selling puts on it today.
Implied volatility is 51% on the near-the-money contracts 20-60 days out - inside the 35-60% range the Wheel Score pays full marks for: enough premium to be worth selling, not so much that the risk is unpaid. Chain open interest is thin - 1,908 contracts across every expiry - so fills at a fair price are not guaranteed; a 30-45-day put may not exist at a usable strike.
Volume runs at 371k shares a day on a market cap of $3.6B, with a beta of 1.32 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score gives that 13 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 0 / 25 | -96% margin of safety | |
| Health | 9 / 20 | Piotroski 4/9 | |
| Moat | 3 / 15 | moat 2.3/10 | |
| Premium | 20 / 20 | implied volatility 51% | |
| Stability | 13 / 20 | 371k shares/day, $3.6B cap, beta 1.32 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
iRhythm Technologies, Inc. reports earnings on 29 Oct 2026 (after the close) - inside the 14-day window the Sunday Scan avoids, because a put sold now would carry the report's gap risk.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Devices
The 12 companies below are the closest to iRhythm Technologies, Inc. by market cap within the Medical - Devices industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| ITGR Integer Holdings Corporation | 126.72 | 78.09 | -62% | 47Weak | $4.3B |
| LIVN LivaNova PLC | 78.50 | 99.67 | +21% | 82Prime | $4.3B |
| NEOG Neogen Corporation | 12.27 | 4.48 | -174% | 45Weak | $2.7B |
| TMDX TransMedics Group, Inc. | 75.52 | 116.64 | +35% | 68Good | $2.6B |
| HAE Haemonetics Corporation | 121.29 | 65.74 | -84% | 60Fair | $5.5B |
| UFPT UFP Technologies, Inc. | 291.10 | 250.97 | -16% | 65Good | $2.3B |
| BFLY Butterfly Network, Inc. | 7.85 | - | - | 44Weak | $2.1B |
| AXGN AxoGen, Inc. | 35.63 | 1.71 | -1982% | 40Weak | $2.1B |
| INSP Inspire Medical Systems, Inc. | 70.12 | 139.36 | +50% | 77Good | $2.0B |
| ESTA Establishment Labs Holdings Inc. | 61.36 | - | - | 45Weak | $1.8B |
| ATEC Alphatec Holdings, Inc. | 10.93 | 7.18 | -52% | 45Weak | $1.7B |
| NVCR Novocure Ltd | 14.41 | - | - | 45Weak | $1.7B |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about IRTC
Is IRTC undervalued right now?
No: at 109.35 the stock trades 96% above the GLS average fair value of 55.77 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.
What is the Wheel Score of IRTC and what does it mean?
IRTC scores 45 out of 100 (Weak). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.
What is the GLS fair value for IRTC?
55.77 per share as of 16 Oct 2026 - the simple average of the 2 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does iRhythm Technologies, Inc. report earnings next?
The next earnings report is due on 29 Oct 2026 (after the close), 13 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does IRTC have listed options, and how liquid are they?
Yes. The nightly snapshot found 456 listed contracts with 1,908 open interest across all expiries and implied volatility of 51% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.